These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6971443)

  • 1. Cell cycle and the differential expression of HLA-A,B and HLA-DR antigens on human B lymphoid cells.
    Sarkar S; Glassy MC; Ferrone S; Jones OW
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7297-301. PubMed ID: 6971443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR and melanoma-associated antigen (p97) expression during the cell cycle in human melanoma cell lines, and the effects of recombinant gamma-interferon: two-color flow cytometric analysis.
    Kameyama K; Takezaki S; Kanzaki T; Nishiyama S
    J Invest Dermatol; 1986 Sep; 87(3):313-8. PubMed ID: 3090158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MHC antigen expression on PHA- and MLC-induced T cell lines with that on T and B lymphoblastoid cell lines by cell cycle dependency.
    Matsui Y; Staunton DE; Shapiro HM; Yunis EJ
    Hum Immunol; 1986 Mar; 15(3):285-301. PubMed ID: 2937757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in antigen expression during the cell cycle of a human B-lymphoblastoid cell line.
    Gesche AH; Ashman LK
    Leuk Res; 1985; 9(1):147-56. PubMed ID: 3157836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antigen density in immune lysis of interferon-treated human lymphoid cells: analysis with monoclonal antibodies to the HLA-A,B antigenic molecular complex and to Ia-like antigens.
    Imai K; Pellegrino MA; Ng AK; Ferrone S
    Scand J Immunol; 1981 Nov; 14(5):529-35. PubMed ID: 6175019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of T cell differentiation antigens and major histocompatibility antigens on activated T cells during the cell cycle.
    Matsui Y; Shapiro HM; Sheehy MJ; Christenson L; Staunton DE; Eynon EE; Yunis EJ
    Eur J Immunol; 1986 Mar; 16(3):248-51. PubMed ID: 3082649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells.
    Srour EF; Brandt JE; Leemhuis T; Ballas CB; Hoffman R
    J Immunol; 1992 Feb; 148(3):815-20. PubMed ID: 1370518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
    Guy K; Meehan RR; Dewar AE; Larhammar D
    Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of surface antigens during the cell cycle in different growth phases of American and African Burkitt's lymphoma cell lines.
    Sieverts H; Alabaster O; Goldschmidts W; Magrath I
    Cancer Res; 1986 Mar; 46(3):1182-8. PubMed ID: 3080238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of CALLA and HLA-DR on a non T non B leukemic cell line by lipid treatment.
    Martyre MC; Vaigot P; Kayibanda M; Rosenfeld C
    Biol Cell; 1984; 52(3):243-8. PubMed ID: 6241834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells specific for different antigens express different HLA-D region products.
    Schendel DJ; Johnson JP
    Eur J Immunol; 1985 Dec; 15(12):1239-43. PubMed ID: 3878791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of class I HLA by interferon-alpha is independent of the cell cycle, but the expression is enhanced by a G1/S block.
    Erusalimsky JD; Gilmore D; Milstein C
    Eur J Immunol; 1987 May; 17(5):623-8. PubMed ID: 3108014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytes.
    Fernandez N; Kurpisz M; Labeta M; Sachs J; Pawelec G
    Immunology; 1992 Sep; 77(1):116-22. PubMed ID: 1383136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.